GLP-1 drug market trends

Tirzepatide market has emerged as one of the most transformative drugs in the global pharmaceutical market, redefining the treatment landscape for both type 2 diabetes and obesity. As a dual GIP and GLP-1 receptor agonist, it delivers superior efficacy in weight reduction and blood glucose management compared to earlier-generation therapies. With rapidly increasing demand, expanding…